Biochem Soc Trans. 2002 Aug;30(4):824-8.

B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders.

Source

Centre for Rheumatology, University College London, Arthur Stanley House, 40-50 Tottenham Street, London W1T 4NJ, UK. jo.edwards@ucl.ac.uk

Abstract

B-lymphocyte depletion therapy is being explored in a wide range of autoimmune disorders. In many, there is early evidence for efficacy, and immunosuppression has not been a major problem. The mechanism of action is unclear, but appears to be consistent with the lowering of autoantibody levels, where relevant antibodies are quantifiable. An interesting finding is the persistence of clinical improvement for periods of 1 year or more after B-lymphocyte return, which supports the concept that stochastic generation of rare pathogenic B-lymphocyte subsets may be a rate-limiting step in pathogenesis.

PMID:: 12196207; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Review Rituximab in autoimmune diseases. [Biomed Pharmacother. 2004]
Review Rituximab in autoimmune diseases.
Virgolini L, Marzocchi V. Biomed Pharmacother. 2004 Jun; 58(5):299-309.
Review How does B cell depletion therapy work, and how can it be improved? [Ann Rheum Dis. 2005]
Review How does B cell depletion therapy work, and how can it be improved?
Clark EA, Ledbetter JA. Ann Rheum Dis. 2005 Nov; 64 Suppl 4:iv77-80.
Review B lymphocyte depletion therapy with rituximab in rheumatoid arthritis. [Rheum Dis Clin North Am. 2004]
Review B lymphocyte depletion therapy with rituximab in rheumatoid arthritis.
Edwards JC, Leandro MJ, Cambridge G. Rheum Dis Clin North Am. 2004 May; 30(2):393-403, viii.
B-cell depletion in autoimmune diseases. Advances in autoimmunity. [Autoimmun Rev. 2009]
B-cell depletion in autoimmune diseases. Advances in autoimmunity.
Guzman Moreno R. Autoimmun Rev. 2009 Jun; 8(7):585-90. Epub 2009 Feb 10.
Review B cell reductive therapy in the treatment of autoimmune diseases: a focus on monoclonal antibody treatment of rheumatoid arthritis. [Hematology. 2005]
Review B cell reductive therapy in the treatment of autoimmune diseases: a focus on monoclonal antibody treatment of rheumatoid arthritis.
Tuscano JM, Martin S, Song K, Wun T. Hematology. 2005 Dec; 10(6):521-7.

See reviews... See all...

Cited by 8 PubMed Central articles

Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy. [BMC Musculoskelet Disord. 2010]
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy.
Lerario A, Cogiamanian F, Marchesi C, Belicchi M, Bresolin N, Porretti L, Torrente Y. BMC Musculoskelet Disord. 2010 Jul 11; 11:157. Epub 2010 Jul 11.
Review Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases. [Clin Exp Immunol. 2009]
Review Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.
Hu C, Wong FS, Wen L. Clin Exp Immunol. 2009 Aug; 157(2):181-90.
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma. [Blood. 2009]
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma.
Rossi EA, Goldenberg DM, Cardillo TM, Stein R, Chang CH. Blood. 2009 Jun 11; 113(24):6161-71. Epub 2009 Apr 16.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune diso...
B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders.
Biochem Soc Trans. 2002 Aug ;30(4):824-8.

PubMed
Replication in genetic studies of complex traits.
Replication in genetic studies of complex traits.
Ann Hum Genet. 2004 Nov ;68(Pt 6):646-57.

PubMed
Human articular chondrocytes produce IL-7 and respond to IL-7 with increased pro...
Human articular chondrocytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13.
Arthritis Res Ther. 2008 ;10(1):R23. Epub 2008 Feb 20 .

PubMed
Intravenous injection of a D1 protein of the Smith proteins postpones murine lup...
Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells.
J Immunol. 2004 Nov 1 ;173(9):5835-42.

PubMed
Fibrosis in connective tissue disease: the role of the myofibroblast and fibrobl...
Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions.
Arthritis Res Ther. 2007 ;9 Suppl 2:S4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: